Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anti-IgE therapy.

Jaine Brownell1, Thomas B Casale

  • 1Division of Allergy and Immunology, Department of Medicine, Creighton University School of Medicine, 601 North 30th Street Suite 5850 Omaha, NE 68131, USA.

Immunology and Allergy Clinics of North America
|October 12, 2004
PubMed
Summary

Anti-immunoglobulin E (IgE) therapy offers a novel approach to treating allergies by reducing IgE levels. This treatment shows promise in alleviating symptoms associated with asthma and allergic rhinitis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Route of Allergen Immunotherapy: A Global Look Into Physicians' Motivations.

Allergy·2026
Same author

The monoclonals: What have we learned and where are we going?

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Pragmatic Strategies for Reducing Variability and Risk in Food Oral Immunotherapy.

Clinical reviews in allergy & immunology·2026
Same author

Pirfenidone and its Derivative: Novel Bronchodilators and Leukocyte Airway Inflammation Inhibitors.

American journal of respiratory cell and molecular biology·2026
Same author

No evidence of a differential treatment effect with omalizumab versus placebo across baseline IgE level and BMI subgroups in patients with chronic spontaneous urticaria.

The journal of allergy and clinical immunology. In practice·2026
Same author

Dupilumab in Patients With Chronic Spontaneous Urticaria: Phase 3 LIBERTY-CSU CUPID Randomized Clinical Trials.

JAMA dermatology·2026

Area of Science:

  • Immunology
  • Allergy Research
  • Pharmacology

Background:

  • Immunoglobulin E (IgE) plays a critical role in initiating allergic hypersensitivity reactions.
  • Allergic diseases such as asthma, allergic rhinitis, and food allergies significantly impact public health.
  • Current treatments aim to manage symptoms, but novel therapeutic strategies are needed.

Purpose of the Study:

  • To evaluate the efficacy of anti-IgE therapy in managing allergic diseases.
  • To elucidate the mechanism of action for anti-IgE therapeutic agents.
  • To explore the potential of anti-IgE therapy in preventing allergic symptom development.

Main Methods:

  • Development of humanized monoclonal antibodies targeting IgE.
  • Administration of anti-IgE therapy to patients with allergic conditions.
  • Monitoring of serum IgE levels and FcepsilonRI expression on immune cells.

Main Results:

  • Anti-IgE therapy effectively reduces serum IgE levels.
  • The treatment leads to decreased FcepsilonRI expression on mast cells and basophils.
  • Clinical benefits observed include prevention of asthma and allergic rhinitis symptoms.

Conclusions:

  • Anti-IgE therapy is a promising, original approach for treating allergic diseases.
  • The mechanism involves reducing key mediators of allergic reactions.
  • Further research supports its role in managing allergic hypersensitivity.

Related Experiment Videos